Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 810,900 | 885,000 | 821,500 | 826,200 | 776,000 |
| Cost of Goods | 650,700 | 672,800 | 626,200 | 630,600 | 614,100 |
| Gross Profit | 160,200 | 212,200 | 195,300 | 195,600 | 161,900 |
| Operating Expenses | 95,100 | 102,800 | 89,800 | 84,500 | 100,100 |
| Operating Income | 65,800 | 110,200 | 105,700 | 111,700 | 61,900 |
| Interest Expense | 73,200 | 74,200 | 80,100 | 73,400 | 67,800 |
| Other Income | 4,100 | 6,600 | 5,200 | 5,500 | 5,600 |
| Pre-tax Income | -3,300 | 42,600 | 30,800 | 43,800 | -300 |
| Income Tax | -1,200 | 13,600 | 5,500 | -1,100 | N/A |
| Net Income Continuous | -2,100 | 29,000 | 25,300 | 44,900 | -300 |
| Minority Interests | 33,800 | 44,000 | 48,000 | 47,400 | 37,400 |
| Net Income | $-35,900 | $-15,000 | $-22,700 | $-2,500 | $-37,700 |
| EPS Basic Total Ops | -0.28 | -0.11 | -0.18 | -0.02 | -0.30 |
| EPS Basic Continuous Ops | -0.02 | 0.23 | 0.20 | 0.35 | 0.00 |
| EPS Diluted Total Ops | -0.28 | -0.11 | -0.18 | -0.02 | -0.30 |
| EPS Diluted Continuous Ops | -0.02 | 0.23 | 0.20 | 0.35 | 0.00 |
| EPS Diluted Before Non-Recurring Items | -0.08 | 0.10 | 0.11 | 0.12 | -0.02 |
| EBITDA(a) | $108,400 | $176,700 | $150,400 | $157,500 | $103,800 |